BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33995277)

  • 21. Diagnostic value of adrenal iodine-131 6-beta-iodomethyl-19-norcholesterol scintigraphy for primary aldosteronism: a retrospective study at a medical center in North Taiwan.
    Wu MH; Liu FH; Lin KJ; Sun JH; Chen ST
    Nucl Med Commun; 2019 Jun; 40(6):568-575. PubMed ID: 30694876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of Japanese aldosterone-producing adenomas with KCNJ5 mutations.
    Okamura T; Nakajima Y; Katano-Toki A; Horiguchi K; Matsumoto S; Yoshino S; Yamada E; Tomaru T; Ishii S; Saito T; Ozawa A; Shibusawa N; Satoh T; Okada S; Nagaoka R; Takada D; Horiguchi J; Oyama T; Yamada M
    Endocr J; 2017 Jan; 64(1):39-47. PubMed ID: 27681703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous scintigraphic depiction of aldosteronoma and adrenal infarction.
    Gianchandani RY; Quin GA; Grekin RJ; Gross MD; Sisson JC; Thompson NW; Shapiro B
    J Nucl Med; 1996 May; 37(5):852-4. PubMed ID: 8965160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas.
    Taguchi R; Yamada M; Nakajima Y; Satoh T; Hashimoto K; Shibusawa N; Ozawa A; Okada S; Rokutanda N; Takata D; Koibuchi Y; Horiguchi J; Oyama T; Takeyoshi I; Mori M
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1311-9. PubMed ID: 22278422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial.
    Dekkers T; Prejbisz A; Kool LJS; Groenewoud HJMM; Velema M; Spiering W; Kołodziejczyk-Kruk S; Arntz M; Kądziela J; Langenhuijsen JF; Kerstens MN; van den Meiracker AH; van den Born BJ; Sweep FCGJ; Hermus ARMM; Januszewicz A; Ligthart-Naber AF; Makai P; van der Wilt GJ; Lenders JWM; Deinum J;
    Lancet Diabetes Endocrinol; 2016 Sep; 4(9):739-746. PubMed ID: 27325147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium.
    Kuppusamy M; Caroccia B; Stindl J; Bandulik S; Lenzini L; Gioco F; Fishman V; Zanotti G; Gomez-Sanchez C; Bader M; Warth R; Rossi GP
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1765-73. PubMed ID: 25057880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas.
    Williams TA; Monticone S; Schack VR; Stindl J; Burrello J; Buffolo F; Annaratone L; Castellano I; Beuschlein F; Reincke M; Lucatello B; Ronconi V; Fallo F; Bernini G; Maccario M; Giacchetti G; Veglio F; Warth R; Vilsen B; Mulatero P
    Hypertension; 2014 Jan; 63(1):188-95. PubMed ID: 24082052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GSTA1 Expression Is Correlated With Aldosterone Level in KCNJ5-Mutated Adrenal Aldosterone-Producing Adenoma.
    Li X; Wang B; Tang L; Zhang Y; Chen L; Gu L; Zhang F; Ouyang J; Zhang X
    J Clin Endocrinol Metab; 2018 Mar; 103(3):813-823. PubMed ID: 29165597
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Chang YY; Tsai CH; Peng SY; Chen ZW; Chang CC; Lee BC; Liao CW; Pan CT; Chen YL; Lin LC; Chang YR; Peng KY; Chou CH; Wu VC; Hung CS; Lin YH;
    Hypertension; 2021 Jan; 77(1):114-125. PubMed ID: 33249859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas.
    Monticone S; Castellano I; Versace K; Lucatello B; Veglio F; Gomez-Sanchez CE; Williams TA; Mulatero P
    Mol Cell Endocrinol; 2015 Aug; 411():146-54. PubMed ID: 25958045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5.
    Scholl UI; Nelson-Williams C; Yue P; Grekin R; Wyatt RJ; Dillon MJ; Couch R; Hammer LK; Harley FL; Farhi A; Wang WH; Lifton RP
    Proc Natl Acad Sci U S A; 2012 Feb; 109(7):2533-8. PubMed ID: 22308486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrolides for KCNJ5-mutated aldosterone-producing adenoma (MAPA): design of a study for personalized diagnosis of primary aldosteronism.
    Maiolino G; Ceolotto G; Battistel M; Barbiero G; Cesari M; Amar L; Caroccia B; Padrini R; Azizi M; Rossi GP
    Blood Press; 2018 Aug; 27(4):200-205. PubMed ID: 29409357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. KCNJ5 Mutation Contributes to Complete Clinical Success in Aldosterone-Producing Adenoma: A Study From a Single Center.
    Zhang C; Wu L; Jiang L; Su T; Zhou W; Zhong X; Xie J; Sun F; Zhu Y; Jiang Y; Wang W
    Endocr Pract; 2021 Jul; 27(7):736-742. PubMed ID: 33678553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. a Novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III.
    Monticone S; Hattangady NG; Penton D; Isales CM; Edwards MA; Williams TA; Sterner C; Warth R; Mulatero P; Rainey WE
    J Clin Endocrinol Metab; 2013 Nov; 98(11):E1861-5. PubMed ID: 24037882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of cardiovascular complications in patients with and without KCNJ5 gene mutations harboring aldosterone-producing adenomas.
    Kitamoto T; Suematsu S; Matsuzawa Y; Saito J; Omura M; Nishikawa T
    J Atheroscler Thromb; 2015; 22(2):191-200. PubMed ID: 25253161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mosaicism for KCNJ5 Causing Early-Onset Primary Aldosteronism due to Bilateral Adrenocortical Hyperplasia.
    Maria AG; Suzuki M; Berthon A; Kamilaris C; Demidowich A; Lack J; Zilbermint M; Hannah-Shmouni F; Faucz FR; Stratakis CA
    Am J Hypertens; 2020 Feb; 33(2):124-130. PubMed ID: 31637427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accuracy of adrenal imaging and adrenal venous sampling in diagnosing unilateral primary aldosteronism.
    Ladurner R; Sommerey S; Buechner S; Dietz A; Degenhart C; Hallfeldt K; Gallwas J
    Eur J Clin Invest; 2017 May; 47(5):372-377. PubMed ID: 28299775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted Molecular Characterization of Aldosterone-Producing Adenomas in White Americans.
    Nanba K; Omata K; Else T; Beck PCC; Nanba AT; Turcu AF; Miller BS; Giordano TJ; Tomlins SA; Rainey WE
    J Clin Endocrinol Metab; 2018 Oct; 103(10):3869-3876. PubMed ID: 30085035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urine steroid metabolomics as a diagnostic tool in primary aldosteronism.
    Prete A; Lang K; Pavlov D; Rhayem Y; Sitch AJ; Franke AS; Gilligan LC; Shackleton CHL; Hahner S; Quinkler M; Dekkers T; Deinum J; Reincke M; Beuschlein F; Biehl M; Arlt W
    J Steroid Biochem Mol Biol; 2024 Mar; 237():106445. PubMed ID: 38104729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Somatic KCNJ5 mutation occurring early in adrenal development may cause a novel form of juvenile primary aldosteronism.
    Tamura A; Nishimoto K; Seki T; Matsuzawa Y; Saito J; Omura M; Gomez-Sanchez CE; Makita K; Matsui S; Moriya N; Inoue A; Nagata M; Sasano H; Nakamura Y; Yamazaki Y; Kabe Y; Mukai K; Kosaka T; Oya M; Suematsu S; Nishikawa T
    Mol Cell Endocrinol; 2017 Feb; 441():134-139. PubMed ID: 27514282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.